Finance

Lists
Q2 2027 earnings • released • EPS beat +8.55% • Revenue beat +2.66%
See results
LALPATHLAB:NSE
Dr. Lal PathLabs Ltd
₹2,045.00
+6.20%
(+119.30) 1D
Nov 4, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LALPATHLAB...
Open
₹1,934.10
High
₹2,049.00
Low
₹1,901.00
Mkt. cap
341.84B
Avg. vol.
271.33K
Volume
735.42K
Dividend
0.78%
Quarterly dividend
₹4.00
Ex-dividend date
Jun 25, 2026
P/E ratio
63.12
52-wk high
₹2,049.00
52-wk low
₹1,272.60
EPS
₹32.40
Shares outstanding
83.34M
No. of employees
5K
Open
₹1,934.10
High
₹2,049.00
Low
₹1,901.00
Mkt. cap
341.84B
Avg. vol.
271.33K
Volume
735.42K
Dividend
0.78%
Quarterly dividend
₹4.00
Ex-dividend date
Jun 25, 2026
P/E ratio
63.12
52-wk high
₹2,049.00
52-wk low
₹1,272.60
EPS
₹32.40
Shares outstanding
83.34M
No. of employees
5K
News stories
From web sources and news partners
Profile
Dr Lal PathLabs Limited is an Indian service provider of diagnostic and related healthcare tests. Based in New Delhi, the company offers tests on blood, urine and other human body viscera. Wikipedia
About Dr. Lal PathLabs Ltd
CEO-
Employees5.21K
Founded1949
Headquarters-
SectorHealth care provider
Industry-
Websitelalpathlabs.com
Last report
Just released
Today, 7:30 AM
Fiscal period
Q2 2027
₹11.47 / ₹10.57
+8.55%beat
Revenue / Est. (INR)
8.74B / 8.51B
+2.66%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.31B
6.60B
7.03B
7.98B
Cost of goods sold
2.74B
2.63B
3.21B
2.84B
Cost of revenue
2.74B
2.63B
3.21B
2.84B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.06B
958.00M
2.32B
1.16B
Operating expense
2.73B
2.59B
2.35B
3.10B
Total operating expenses
5.47B
5.23B
5.55B
5.95B
Operating income
1.84B
1.37B
1.47B
2.03B
Other non operating income
248.00M
244.00M
-752.10M
319.00M
EBT including unusual items
2.04B
1.24B
1.60B
2.29B
EBT excluding unusual items
2.04B
1.54B
1.33B
2.29B
Income tax expense
514.00M
329.00M
279.31M
582.00M
Effective tax rate
25.25%
26.47%
17.45%
25.45%
Other operating expenses
1.26B
1.22B
-425.41M
1.50B
Net income
1.51B
905.00M
1.31B
1.70B
Net profit margin
20.61%
13.72%
18.68%
21.25%
Earnings per share
9.00
6.73
8.44
10.13
Interest and investment income
-
-
670.12M
-
Interest expense
-48.00M
-72.00M
-61.00M
-63.00M
Net interest expenses
-48.00M
-72.00M
609.12M
-63.00M
Depreciation and amortization charges
405.00M
421.00M
446.03M
444.00M
EBITDA
2.21B
1.62B
1.76B
2.32B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps